Global Dry Powder Inhalers Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Dry Powder Inhalers market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Dry Powder Inhalers market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Dry powder inhalers (DPIs) are medical devices used to deliver medication directly into the lungs for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Unlike traditional inhalers that deliver medication in aerosol form, DPIs release a fine powder that the patient inhales into their lungs by taking a deep breath. The device typically consists of a reservoir containing the powdered medication and a mechanism to create a fine powder suitable for inhalation. DPIs are popular due to their ease of use and lack of propellants, making them environmentally friendly. Proper inhalation technique is important for effective medication delivery, as the patient＇s breath generates the airflow needed to disperse the powder. DPIs provide a convenient and efficient way to administer respiratory medications, improving patients＇ lung function and overall quality of life.
The major global manufacturers of Dry Powder Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Novartis, Mylan, Schering/Merck, Teva, Vectura, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Dry Powder Inhalers. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dry Powder Inhalers market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Dry Powder Inhalers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dry Powder Inhalers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dry Powder Inhalers Include:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Novartis
Mylan
Schering/Merck
Teva
Vectura
Dry Powder Inhalers Product Segment Include:
Single Dose Inhaler
Multidose Inhaler
Dry Powder Inhalers Product Application Include:
Asthma
Chronic Obstructive Pulmonary Disease
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Dry Powder Inhalers Industry PESTEL Analysis
Chapter 3: Global Dry Powder Inhalers Industry Porter's Five Forces Analysis
Chapter 4: Global Dry Powder Inhalers Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Dry Powder Inhalers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Dry Powder Inhalers Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Dry Powder Inhalers Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Dry Powder Inhalers market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Dry Powder Inhalers market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Dry powder inhalers (DPIs) are medical devices used to deliver medication directly into the lungs for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Unlike traditional inhalers that deliver medication in aerosol form, DPIs release a fine powder that the patient inhales into their lungs by taking a deep breath. The device typically consists of a reservoir containing the powdered medication and a mechanism to create a fine powder suitable for inhalation. DPIs are popular due to their ease of use and lack of propellants, making them environmentally friendly. Proper inhalation technique is important for effective medication delivery, as the patient＇s breath generates the airflow needed to disperse the powder. DPIs provide a convenient and efficient way to administer respiratory medications, improving patients＇ lung function and overall quality of life.
The major global manufacturers of Dry Powder Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Novartis, Mylan, Schering/Merck, Teva, Vectura, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Dry Powder Inhalers. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dry Powder Inhalers market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Dry Powder Inhalers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dry Powder Inhalers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dry Powder Inhalers Include:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Novartis
Mylan
Schering/Merck
Teva
Vectura
Dry Powder Inhalers Product Segment Include:
Single Dose Inhaler
Multidose Inhaler
Dry Powder Inhalers Product Application Include:
Asthma
Chronic Obstructive Pulmonary Disease
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Dry Powder Inhalers Industry PESTEL Analysis
Chapter 3: Global Dry Powder Inhalers Industry Porter's Five Forces Analysis
Chapter 4: Global Dry Powder Inhalers Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Dry Powder Inhalers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Dry Powder Inhalers Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Dry Powder Inhalers Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Dry Powder Inhalers Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Dry Powder Inhalers Product by Type
- 1.2.1 Single Dose Inhaler
- 1.2.2 Multidose Inhaler
- 1.3 Dry Powder Inhalers Product by Application
- 1.3.1 Asthma
- 1.3.2 Chronic Obstructive Pulmonary Disease
- 1.3.3 Other
- 1.4 Global Dry Powder Inhalers Market Revenue and Sales Analysis
- 1.4.1 Global Dry Powder Inhalers Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Dry Powder Inhalers Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Dry Powder Inhalers Market Sales Price Trend Analysis (2020-2032)
- 1.5 Dry Powder Inhalers Market Development Status and Trends
- 1.5.1 Dry Powder Inhalers Industry Development Status Analysis
- 1.5.2 Dry Powder Inhalers Industry Development Trends Analysis
- 2 Dry Powder Inhalers Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Dry Powder Inhalers Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Dry Powder Inhalers Market Analysis by Country
- 4.1 Global Dry Powder Inhalers Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Dry Powder Inhalers Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Dry Powder Inhalers Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Dry Powder Inhalers Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Dry Powder Inhalers Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Dry Powder Inhalers Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Dry Powder Inhalers Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Dry Powder Inhalers Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Dry Powder Inhalers Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Dry Powder Inhalers Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Dry Powder Inhalers Average Sales Price by Manufacturers (2021-2025)
- 5.2 Dry Powder Inhalers Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Dry Powder Inhalers Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Dry Powder Inhalers Market Analysis by Type
- 6.1 Global Dry Powder Inhalers Market Revenue Analysis by Type
- 6.1.1 Global Dry Powder Inhalers Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Dry Powder Inhalers Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Dry Powder Inhalers Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Dry Powder Inhalers Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 GlaxoSmithKline
- 7.1.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 GlaxoSmithKline Dry Powder Inhalers Product Portfolio
- 7.1.3 GlaxoSmithKline Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 AstraZeneca
- 7.2.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 AstraZeneca Dry Powder Inhalers Product Portfolio
- 7.2.3 AstraZeneca Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Boehringer Ingelheim
- 7.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Boehringer Ingelheim Dry Powder Inhalers Product Portfolio
- 7.3.3 Boehringer Ingelheim Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Chiesi
- 7.4.1 Chiesi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Chiesi Dry Powder Inhalers Product Portfolio
- 7.4.3 Chiesi Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Cipla
- 7.5.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Cipla Dry Powder Inhalers Product Portfolio
- 7.5.3 Cipla Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 3M
- 7.6.1 3M Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 3M Dry Powder Inhalers Product Portfolio
- 7.6.3 3M Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Hovione
- 7.7.1 Hovione Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Hovione Dry Powder Inhalers Product Portfolio
- 7.7.3 Hovione Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Mannkind
- 7.8.1 Mannkind Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Mannkind Dry Powder Inhalers Product Portfolio
- 7.8.3 Mannkind Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Novartis
- 7.9.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Novartis Dry Powder Inhalers Product Portfolio
- 7.9.3 Novartis Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Mylan
- 7.10.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Mylan Dry Powder Inhalers Product Portfolio
- 7.10.3 Mylan Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Schering/Merck
- 7.11.1 Schering/Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Schering/Merck Dry Powder Inhalers Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
